1. NEXGEL Eyes $35M Pro Forma Revenue After Acquiring Celularity's Wound Segment
NEXGEL is projecting a significant leap in its financial scale, anticipating pro forma annual revenue of approximately $35 million following its strategic acquisition of the wound care segment from Celularity Inc. This move instantly reshapes the hydrogel technology company's market position, transforming its revenue p...